Cancer Immunology is also known as tumour immunology. It is a branch of immunology that studies interactions between the immune systems and the cancer cells. It is a growing field of research that aims to get innovative cancer immunotherapies to treat and retard progression of the disease. The journal is a forum for brand spanking new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. CIJ is keen to publish broad-ranging ideas and reviews, results which extend or challenge established paradigms, also as negative studies which fail to breed experiments that support current paradigms, and papers that do succeed in reproducing others’ results in different contexts. Cll is particularly curious about papers describing clinical test designs and outcome no matter whether or not they met their designated endpoints or not, and particularly those shedding light on immunological mechanisms.